Alessio Aghemo, Maria Francesca Donato Gastroenterology

Slides:

Advertisements

Similar presentations

Ashutosh Gupta, Bashar M. Attar, Vikram Kotwal

Advertisements

Volume 149, Issue 6, Pages (November 2015)

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Volume 152, Issue 4, Pages (March 2017)

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers Thilo Rattay, Ian P. Dumont, Hauke.

Covering the Cover Gastroenterology

Volume 149, Issue 6, Pages (November 2015)

Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis

New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

Effectiveness of Hepatitis B Treatment in Clinical Practice

Volume 153, Issue 4, Pages (October 2017)

Cost-Effectiveness Analysis of New HCV Treatments in Egyptian Cirrhotic and Non- Cirrhotic Patients: A Societal Perspective Gihan Hamdy Elsisi, MSc, PhD,

Is HCV Infection a Neurologic Disorder?

Outcomes Among Living Liver Donors

Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection Tobias Boettler, Robert Thimme Gastroenterology

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin Jean–François Rossignol, Asem Elfert,

Ira J. Fox, Stephen C. Strom Gastroenterology

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus Amit G. Singal, Michael.

Volume 134, Issue 5, Pages (May 2008)

The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?

Volume 135, Issue 4, Pages (October 2008)

Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH

Volume 150, Issue 4, Pages (April 2016)

Volume 154, Issue 4, Pages (March 2018)

Yasuhiko Sugawara, Masatoshi Makuuchi

Volume 155, Issue 5, Pages e2 (November 2018)

Jean-Michel Pawlotsky Gastroenterology

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening Brianna L. Norton,

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 138, Issue 1, Pages (January 2010)

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

A. Sidney Barritt, Michael W. Fried Gastroenterology

Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill

The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related.

Volume 142, Issue 6, Pages e3 (May 2012)

Issue Highlights Clinical Gastroenterology and Hepatology

Volume 142, Issue 6, Pages (May 2012)

Enrico N. De Toni, Alexander L. Gerbes Gastroenterology

Rafael Esteban, Maria Buti Gastroenterology

Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong

Volume 133, Issue 2, Pages (August 2007)

Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 152, Issue 1, Pages (January 2017)

Volume 148, Issue 3, Pages (March 2015)

Genetic Factors and Hepatitis C Virus Infection

Volume 70, Issue 1, Pages (January 2019)

Jeremy P. Dwyer, Patrick Hosking, John Lubel Gastroenterology

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

Covering the Cover Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Hepatitis C treatment in patients with kidney disease

Christos Konstantakis, Maria Karamesini, Christos Triantos

Changing of the Guards: 2011–2016 Gastroenterology Team

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Michelle Maria Pietzak Gastroenterology

Volume 155, Issue 6, Pages (December 2018)

Volume 139, Issue 5, Pages (November 2010)

Volume 147, Issue 6, Pages (December 2014)

Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction? Masaru Enomoto, Yoshiki Murakami,

Kathleen E. Corey, Andrew S

Controversies in Liver Transplantation for Hepatitis C

Volume 135, Issue 5, Pages (November 2008)

The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.

Volume 148, Issue 1, Pages (January 2015)

Fasiha Kanwal, Tuyen Hoang, Timothy Chrusciel, Jennifer R

Reversion of disease manifestations after HCV eradication

A Rare Tumor of the Liver With a Sudden Presentation

Presentation transcript:

Sofosbuvir Treatment in the Pre and Post Liver Transplantation Phase: The Sooner, the Better Alessio Aghemo, Maria Francesca Donato Gastroenterology Volume 148, Issue 1, Pages 13-16 (January 2015) DOI: 10.1053/j.gastro.2014.11.025 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Possible therapeutic strategies for patients with hepatitis C virus (HCV) infection before and after liver transplantation (LT). GFR, glomerular filtration rate; RBV, ribavirin; SOF, sofosbuvir; SVR, sustained virologic response. Gastroenterology 2015 148, 13-16DOI: (10.1053/j.gastro.2014.11.025) Copyright © 2015 AGA Institute Terms and Conditions